(Q51107835)

30 March 2018

title

Levodopa in Parkinsonism: Potentiation of Central Effects with a Peripheral Inhibitor (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

2 February 2023

1 reference

1 reference

parkinsonian syndrome

1 reference

P. S. Papavasiliou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4550085

2 February 2023

G. C. Cotzias

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4550085

2 February 2023

S. E. Düby

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4550085

2 February 2023

A. J. Steck

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4550085

2 February 2023

C. Fehling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4550085

2 February 2023

M. A. Bell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4550085

2 February 2023

language of work or name

English

0 references

publication date

1 January 1972

1 reference

30 March 2018

6 January 1972

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4550085

full work available at URL

2 February 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197201062860102

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

The New England Journal of Medicine

2 February 2023

published in

1 reference

30 March 2018

volume

286

1 reference

30 March 2018

issue

1

1 reference

30 March 2018

page(s)

8-14

1 reference

30 March 2018

Modification of Parkinsonism--chronic treatment with L-dopa

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).

2 February 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Treatment of Parkinsonism With Levodopa

2 February 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Metabolic modification of Parkinson's disease and of chronic manganese poisoning

2 February 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

2 February 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Munchener medizinische Wochenschrift (1950)

2 February 2023

8

96

637

Finke

1954

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

2 February 2023

Pharmacological Reviews

9

16

113

Holtz

1964

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine

2 February 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane

2 February 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

2 February 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Measurement of compounds of vitamin B6 group in blood

2 February 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

The reaction of pyridoxal 5-phosphate with cyanide and its analytical use

2 February 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Aromatic Amino Acids and Modification of Parkinsonism

2 February 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

2 February 2023

Pharmacological Reviews

21

18

53

Sourkes

1966

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

O-Methylation of Epinephrine and Other Catechols in vitro and in vivo

2 February 2023

22

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Pyridoxine for Levodopa-Induced Dystonia

2 February 2023

24

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Levodopa, Pyridoxine, and The Burning Feet Syndrome

2 February 2023

25

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Metabolic modification of some neurologic disorders

2 February 2023

26

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Blocking the Negative Effects of Pyridoxine on Patients Receiving Levodopa

2 February 2023

27

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine

2 February 2023

28

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

The role of vitamin B6 in the toxicity of hydrazines

2 February 2023

29

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Effects of isoniazid on pyridoxine metabolism

2 February 2023

30

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

2 February 2023

Vienna Clinical Weekly

32

81

677

Birkmayer

1969

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

2 February 2023

33

77

619

Tissot

1969

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

Deutsche Zeitschrift fur Nervenheilkunde

2 February 2023

35

197

85

Kaufmann

1969

1 reference

https://api.crossref.org/works/10.1056/NEJM197201062860102

2 February 2023

Identifiers

1 reference

30 March 2018

1 reference

30 March 2018